Bioscience Company Announces FDA Approval For Ovarian Cancer Treatment
Anixa Biosciences Announces FDA Approval of Individual Patient IND for Ovarian Cancer CAR-T Therapy.
Disclaimer: This article is for informational purposes only and does not constitute financial, medical, or legal advice. The content herein reflects current information as of the publication date and should not be relied upon for making any investment, medical, or other important decisions.
Real-time information is available daily…